Sort
85,873 grants matching “alzheimers”
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028
$6,700,232Josef Coresh · New York University School Of Medicine · U01 · FY2024 · HL
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
$6,682,055John Alam · Eip Pharma, Inc. · R01 · FY2023 · AG
Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease
$6,679,538Hector M Gonzalez · University Of California, San Diego · R01 · FY2022 · AG
Core D: Neuroimaging Core
$6,650,768Bradley T Christian · University Of Pittsburgh At Pittsburgh · U19 · FY2023 · AG
Administrative Core (AC) Core A
$6,648,026Carol A. Barnes · University Of Arizona · U19 · FY2022 · AG
VULNERABILITY AND RESILIENCY IN THE AGING ADULT BRAIN CONNECTOME (AABC)
$6,640,514Beau M Ances · Washington University · U19 · FY2021 · AG
Neurocognitive aging, MCI and Alzheimer's disease DNA methylation among diverse Latinos
$6,630,354Hector M Gonzalez · University Of California, San Diego · RF1 · FY2019 · AG
Center for Alzheimer's and Related Dementias: First stage single-cell brain resource for Alzheimer's disease and related dementias
$6,627,513Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028
$6,605,599Josef Coresh · New York University School Of Medicine · U01 · FY2025 · HL
Einstein Aging Study
$6,602,838Carol A Derby · Albert Einstein College Of Medicine · P01 · FY2022 · AG
VULNERABILITY AND RESILIENCY IN THE AGING ADULT BRAIN CONNECTOME (AABC)
$6,590,217Beau M Ances · Washington University · U19 · FY2025 · AG
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
$6,580,973Roberta Diaz Brinton · University Of Arizona · R01 · FY2025 · AG
Biology and pathobiology of apoE in aging and Alzheimer's disease
$6,571,383Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2022 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS
$6,558,676University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AT
Dominantly Inherited Alzheimer Network
$6,556,948Randall J Bateman · Washington University · U19 · FY2022 · AG
Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative
$6,545,108Margaret A Pericak-Vance · University Of Miami School Of Medicine · U01 · FY2024 · AG
API A4 Alzheimer's Prevention Trial
$6,538,660Eric M Reiman · Banner Health · R01 · FY2024 · AG
Cyclotron, PET and MRI Facility Improvement: A Scientific Resource for Arizona
$6,530,203Eric M Reiman · Banner Alzheimer'S Institute · C06 · FY2010 · RR
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
$6,526,335Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2023 · AG
Biology and pathobiology of apoE in aging and Alzheimer's disease
$6,523,942Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2023 · AG
Defining the effect of Alzheimer pathologies on the aged brain in 3 dimensions
$6,518,197Philip L De Jager · Columbia University Health Sciences · U19 · FY2023 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$6,500,000Susan Abushakra · Alzheon, Inc. · R01 · FY2023 · AG
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease
$6,488,333Eric M Reiman · Banner Health · R01 · FY2022 · AG
Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)
$6,484,025Margaret A Pericak-Vance · University Of Miami School Of Medicine · U01 · FY2018 · AG
Einstein Aging Study
$6,483,445Carol A Derby · Albert Einstein College Of Medicine · P01 · FY2023 · AG